seen from China
seen from Malaysia
seen from Argentina
seen from United States
seen from Bangladesh
seen from United States
seen from Germany
seen from Yemen
seen from United States
seen from United States
seen from United States
seen from United States
seen from Norway
seen from Romania
seen from Türkiye
seen from United States
seen from Argentina
seen from United States
seen from Russia
seen from France
Arkon Solutions and the Impact of Lumakras in India
Experience the transformative impact of Lumakras in India through Arkon Solutions. Delve into how our collaboration is reshaping the healthcare landscape, providing advanced solutions and empowering lives with innovative treatments for a healthier nation.
The approval of registering and using “Lumakras” for the treatment of lung cancer in the UAE, reflects the keenness of our wise leadership to consolidate its position in the global therapeutic market, and give it a differential advantage.
FDA APPROVAL - KRAS & NSCLC The #FDA has granted accelerated approval to #sotorasib (#Lumakras) for the treatment of adult patients with #KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy, according to a press release from Amgen.1 https://lnkd.in/gSC6N7r #MSL #MSLS #medicalaffairs #BCMSL #BoardCertifiedMSL #TheMSLcommunity Msl society #FSTP #medicalscienceliaison #health #healthcare Phdlife #phd #pharmd#MSLsalary #pharmacist #phd #phdlife Amgen https://www.instagram.com/p/CPfmnPGDKiV/?utm_medium=tumblr
